CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease

Immun Inflamm Dis. 2022 Jul;10(7):e644. doi: 10.1002/iid3.644.

Abstract

Chromodomain helicase DNA binding protein 4 (CHD4) is an ATPase subunit of the nucleosome remodeling and deacetylation complex. It has been implicated in gene transcription, DNA damage repair, maintenance of genome stability, and chromatin assembly. Meanwhile, it is highly related to cell cycle progression and the proceeding of malignancy. Most of the previous studies were focused on the function of CHD4 with tumor cells, cancer stem cells, and cancer cells multidrug resistance. Recently, some researchers have explored the CHD4 functions on the development and differentiation of adaptive immune cells, such as T and B lymphocytes. In this review, we will discuss details of CHD4 in lymphocyte differentiation and development, as well as the critical role of CHD4 in the pathogenesis of the autoimmune disease.

Keywords: B cells; T cells; autoimmune disease; chromodomain helicase DNA binding protein 4; nucleosome remodeling and deacetylation complex.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases*
  • B-Lymphocytes / metabolism
  • Cell Differentiation
  • Chromatin Assembly and Disassembly*
  • Humans
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex / genetics
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex / metabolism
  • Nucleosomes
  • T-Lymphocytes

Substances

  • CHD4 protein, human
  • Nucleosomes
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex